Chronic obstructive pulmonary disease Respiratory
Conditions
Interventions
Utilizing a Target Trial Emulation (TTE) design on real-world data (Jan 2019–Dec 2024) from four Chinese tertiary hospitals, this study evaluates HBF effect on 1-year readmission risks. To mitigate co
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Third Affiliated Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 84 Years
Inclusion criteria
Inclusion criteria: 1. Age 40–84 years 2. Diagnosis of COPD or AECOPD, validated by spirometry or clinical history 3. Verified survival >1 year (indicated by =1 outpatient record)
Exclusion criteria
Exclusion criteria: 1. Patients admitted for reasons other than COPD (i.e., COPD was not the primary diagnosis) 2. Patients with confounding pulmonary conditions, such as lung malignant neoplasm, pulmonary tuberculosis, thoracic trauma, interstitial lung disease, or lung diseases due to external agents 3. Patients with mental disorders who are unable to cooperate with treatment 4.Patients during pregnancy and lactation 5. Patients did not use TCM throughout hospitalization 6. Patients with consecutive hospitalizations, those discharged against medical advice, transferred to other wards, or with a hospital stay of less than 3 days
Countries
China
Contacts
Public ContactXiaomeng Cheng
Outcome results
None listed